APO Research
Talk to an analyst

APO RESEARCH · REPORT

Carbetocin (Duratocin)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Carbetocin (Duratocin) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025199 pages

Choose your research edition.

Industry ResearchCarbetocin (Duratocin) Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Carbetocin (Duratocin) Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Carbetocin (Duratocin) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Carbetocin (Duratocin) Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Carbetocin (Duratocin) Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Carbetocin (Duratocin) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Carbetocin (Duratocin) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Carbetocin (Duratocin) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Carbetocin (Duratocin) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Carbetocin (Duratocin) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Carbetocin (Duratocin) include Ferring Inc., Hangzhou Dayangchem Co. Ltd., Acinopeptide Co., Ltd., Polypeptide Laboraries France, Leap Labchem Co., Ltd, Clearsynth Canada INC., Chemos GmbH & Co. KG, Chemieliva Pharmaceutical Co., Ltd. and BOC Sciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Carbetocin (Duratocin) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Carbetocin (Duratocin) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Carbetocin (Duratocin) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Carbetocin (Duratocin) market size, projected growth trends, production technologies, key applications, and end-use industries.

Carbetocin (Duratocin) Segment by Company

Ferring Inc.

Hangzhou Dayangchem Co. Ltd.

Acinopeptide Co., Ltd.

Polypeptide Laboraries France

Leap Labchem Co., Ltd

Clearsynth Canada INC.

Chemos GmbH & Co. KG

Chemieliva Pharmaceutical Co., Ltd.

BOC Sciences

Beacon Pharmaceuticals Limited

Bachem AG

Acinopeptide Co., Ltd.

Carbetocin (Duratocin) Segment by Type

Carbetocin Tablets

Carbetocin Injection

Carbetocin (Duratocin) Segment by Application

Oxytocic

Antihemorrhagic

Uterotonic

Carbetocin (Duratocin) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Carbetocin (Duratocin) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Carbetocin (Duratocin) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Carbetocin (Duratocin).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Carbetocin (Duratocin) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Carbetocin (Duratocin) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Carbetocin (Duratocin) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Carbetocin (Duratocin) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Carbetocin (Duratocin) Industry Trends Table 2. Carbetocin (Duratocin) Industry Drivers Table 3. Carbetocin (Duratocin) Industry Opportunities and Challenges Table 4. Carbetocin (Duratocin) Industry Restraints Table 5. Global Carbetocin (Duratocin) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Carbetocin (Duratocin) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Carbetocin (Duratocin) Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Carbetocin (Duratocin) Sales Market Share by Manufacturers Table 9. Global Carbetocin (Duratocin) Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Carbetocin (Duratocin) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Carbetocin (Duratocin) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Carbetocin (Duratocin) Manufacturers, Product Type & Application Table 13. Global Carbetocin (Duratocin) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Carbetocin (Duratocin) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Carbetocin Tablets Table 17. Major Manufacturers of Carbetocin Injection Table 18. Global Carbetocin (Duratocin) Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Carbetocin (Duratocin) Sales by Type (2021-2026) & (k units) Table 20. Global Carbetocin (Duratocin) Sales by Type (2027-2032) & (k units) Table 21. Global Carbetocin (Duratocin) Sales Market Share by Type (2021-2026) Table 22. Global Carbetocin (Duratocin) Sales Market Share by Type (2027-2032) Table 23. Global Carbetocin (Duratocin) Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Carbetocin (Duratocin) Revenue by Type (2021-2026) & (k units) Table 25. Global Carbetocin (Duratocin) Revenue by Type (2027-2032) & (k units) Table 26. Global Carbetocin (Duratocin) Revenue Market Share by Type (2021-2026) Table 27. Global Carbetocin (Duratocin) Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Oxytocic Table 29. Major Manufacturers of Antihemorrhagic Table 30. Major Manufacturers of Uterotonic Table 31. Global Carbetocin (Duratocin) Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Carbetocin (Duratocin) Sales by Application (2021-2026) & (k units) Table 33. Global Carbetocin (Duratocin) Sales by Application (2027-2032) & (k units) Table 34. Global Carbetocin (Duratocin) Sales Market Share by Application (2021-2026) Table 35. Global Carbetocin (Duratocin) Sales Market Share by Application (2027-2032) Table 36. Global Carbetocin (Duratocin) Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Carbetocin (Duratocin) Revenue by Application (2021-2026) & (k units) Table 38. Global Carbetocin (Duratocin) Revenue by Application (2027-2032) & (k units) Table 39. Global Carbetocin (Duratocin) Revenue Market Share by Application (2021-2026) Table 40. Global Carbetocin (Duratocin) Revenue Market Share by Application (2027-2032) Table 41. Global Carbetocin (Duratocin) Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Carbetocin (Duratocin) Sales by Region (2021-2026) & (k units) Table 43. Global Carbetocin (Duratocin) Sales Market Share by Region (2021-2026) Table 44. Global Carbetocin (Duratocin) Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Carbetocin (Duratocin) Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Carbetocin (Duratocin) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Carbetocin (Duratocin) Sales by Country (2021-2026) & (k units) Table 48. North America Carbetocin (Duratocin) Sales by Country (2027-2032) & (k units) Table 49. Europe Carbetocin (Duratocin) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Carbetocin (Duratocin) Sales by Country (2021-2026) & (k units) Table 51. Europe Carbetocin (Duratocin) Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Carbetocin (Duratocin) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Carbetocin (Duratocin) Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Carbetocin (Duratocin) Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Carbetocin (Duratocin) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Carbetocin (Duratocin) Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Carbetocin (Duratocin) Sales by Country (2027-2032) & (k units) Table 58. Global Carbetocin (Duratocin) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Carbetocin (Duratocin) Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Carbetocin (Duratocin) Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Carbetocin (Duratocin) Revenue Market Share by Region (2021-2026) Table 62. Global Carbetocin (Duratocin) Revenue Market Share by Region (2027-2032) Table 63. Ferring Inc. Company Information Table 64. Ferring Inc. Business Overview Table 65. Ferring Inc. Carbetocin (Duratocin) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Ferring Inc. Carbetocin (Duratocin) Product Portfolio Table 67. Ferring Inc. Recent Development Table 68. Hangzhou Dayangchem Co. Ltd. Company Information Table 69. Hangzhou Dayangchem Co. Ltd. Business Overview Table 70. Hangzhou Dayangchem Co. Ltd. Carbetocin (Duratocin) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Hangzhou Dayangchem Co. Ltd. Carbetocin (Duratocin) Product Portfolio Table 72. Hangzhou Dayangchem Co. Ltd. Recent Development Table 73. Acinopeptide Co., Ltd. Company Information Table 74. Acinopeptide Co., Ltd. Business Overview Table 75. Acinopeptide Co., Ltd. Carbetocin (Duratocin) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Acinopeptide Co., Ltd. Carbetocin (Duratocin) Product Portfolio Table 77. Acinopeptide Co., Ltd. Recent Development Table 78. Polypeptide Laboraries France Company Information Table 79. Polypeptide Laboraries France Business Overview Table 80. Polypeptide Laboraries France Carbetocin (Duratocin) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Polypeptide Laboraries France Carbetocin (Duratocin) Product Portfolio Table 82. Polypeptide Laboraries France Recent Development Table 83. Leap Labchem Co., Ltd Company Information Table 84. Leap Labchem Co., Ltd Business Overview Table 85. Leap Labchem Co., Ltd Carbetocin (Duratocin) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Leap Labchem Co., Ltd Carbetocin (Duratocin) Product Portfolio Table 87. Leap Labchem Co., Ltd Recent Development Table 88. Clearsynth Canada INC. Company Information Table 89. Clearsynth Canada INC. Business Overview Table 90. Clearsynth Canada INC. Carbetocin (Duratocin) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Clearsynth Canada INC. Carbetocin (Duratocin) Product Portfolio Table 92. Clearsynth Canada INC. Recent Development Table 93. Chemos GmbH & Co. KG Company Information Table 94. Chemos GmbH & Co. KG Business Overview Table 95. Chemos GmbH & Co. KG Carbetocin (Duratocin) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Chemos GmbH & Co. KG Carbetocin (Duratocin) Product Portfolio Table 97. Chemos GmbH & Co. KG Recent Development Table 98. Chemieliva Pharmaceutical Co., Ltd. Company Information Table 99. Chemieliva Pharmaceutical Co., Ltd. Business Overview Table 100. Chemieliva Pharmaceutical Co., Ltd. Carbetocin (Duratocin) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Chemieliva Pharmaceutical Co., Ltd. Carbetocin (Duratocin) Product Portfolio Table 102. Chemieliva Pharmaceutical Co., Ltd. Recent Development Table 103. BOC Sciences Company Information Table 104. BOC Sciences Business Overview Table 105. BOC Sciences Carbetocin (Duratocin) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. BOC Sciences Carbetocin (Duratocin) Product Portfolio Table 107. BOC Sciences Recent Development Table 108. Beacon Pharmaceuticals Limited Company Information Table 109. Beacon Pharmaceuticals Limited Business Overview Table 110. Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Product Portfolio Table 112. Beacon Pharmaceuticals Limited Recent Development Table 113. Bachem AG Company Information Table 114. Bachem AG Business Overview Table 115. Bachem AG Carbetocin (Duratocin) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Bachem AG Carbetocin (Duratocin) Product Portfolio Table 117. Bachem AG Recent Development Table 118. Acinopeptide Co., Ltd. Company Information Table 119. Acinopeptide Co., Ltd. Business Overview Table 120. Acinopeptide Co., Ltd. Carbetocin (Duratocin) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Acinopeptide Co., Ltd. Carbetocin (Duratocin) Product Portfolio Table 122. Acinopeptide Co., Ltd. Recent Development Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Carbetocin (Duratocin) Distributors List Table 126. Carbetocin (Duratocin) Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Carbetocin (Duratocin) Product Image Figure 2. Global Carbetocin (Duratocin) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Carbetocin (Duratocin) Market Size (2021-2032) & (US$ Million) Figure 4. Global Carbetocin (Duratocin) Sales (2021-2032) & (k units) Figure 5. Global Carbetocin (Duratocin) Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Carbetocin (Duratocin) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Carbetocin Tablets Image Figure 9. Carbetocin Injection Image Figure 10. Global Carbetocin (Duratocin) Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Carbetocin (Duratocin) Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Carbetocin (Duratocin) Sales Market Share by Type (2021-2032) Figure 13. Global Carbetocin (Duratocin) Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Carbetocin (Duratocin) Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Carbetocin (Duratocin) Revenue Market Share by Type (2021-2032) Figure 16. Oxytocic Image Figure 17. Antihemorrhagic Image Figure 18. Uterotonic Image Figure 19. Global Carbetocin (Duratocin) Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Carbetocin (Duratocin) Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Carbetocin (Duratocin) Sales Market Share by Application (2021-2032) Figure 22. Global Carbetocin (Duratocin) Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Carbetocin (Duratocin) Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Carbetocin (Duratocin) Revenue Market Share by Application (2021-2032) Figure 25. North America Carbetocin (Duratocin) Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Carbetocin (Duratocin) Sales Market Share by Country (2021-2032) Figure 27. U.S. Carbetocin (Duratocin) Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Carbetocin (Duratocin) Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Carbetocin (Duratocin) Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Carbetocin (Duratocin) Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Carbetocin (Duratocin) Sales Market Share by Country (2021-2032) Figure 32. Germany Carbetocin (Duratocin) Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Carbetocin (Duratocin) Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Carbetocin (Duratocin) Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Carbetocin (Duratocin) Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Carbetocin (Duratocin) Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Carbetocin (Duratocin) Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Carbetocin (Duratocin) Sales Market Share by Country (2021-2032) Figure 39. China Carbetocin (Duratocin) Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Carbetocin (Duratocin) Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Carbetocin (Duratocin) Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Carbetocin (Duratocin) Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Carbetocin (Duratocin) Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Carbetocin (Duratocin) Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Carbetocin (Duratocin) Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Carbetocin (Duratocin) Sales Market Share by Country (2021-2032) Figure 47. Brazil Carbetocin (Duratocin) Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Carbetocin (Duratocin) Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Carbetocin (Duratocin) Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Carbetocin (Duratocin) Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Carbetocin (Duratocin) Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Carbetocin (Duratocin) Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Carbetocin (Duratocin) Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Carbetocin (Duratocin) Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Carbetocin (Duratocin) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Carbetocin (Duratocin) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Carbetocin (Duratocin) Revenue (2021-2032) & (US$ Million) Figure 58. North America Carbetocin (Duratocin) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Carbetocin (Duratocin) Revenue (2021-2032) & (US$ Million) Figure 60. Europe Carbetocin (Duratocin) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Carbetocin (Duratocin) Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Carbetocin (Duratocin) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Carbetocin (Duratocin) Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Carbetocin (Duratocin) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Carbetocin (Duratocin) Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Carbetocin (Duratocin) Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Carbetocin Tablets
  • Carbetocin Injection
Applications
  • Oxytocic
  • Antihemorrhagic
  • Uterotonic
Companies covered
  • Ferring Inc.
  • Hangzhou Dayangchem Co. Ltd.
  • Acinopeptide Co., Ltd.
  • Polypeptide Laboraries France
  • Leap Labchem Co., Ltd
  • Clearsynth Canada INC.
  • Chemos GmbH & Co. KG
  • Chemieliva Pharmaceutical Co., Ltd.
  • BOC Sciences
  • Beacon Pharmaceuticals Limited
  • Bachem AG
  • Acinopeptide Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Carbetocin (Duratocin) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Carbetocin (Duratocin) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Carbetocin (Duratocin) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Carbetocin (Duratocin) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Carbetocin (Duratocin) Market Dynamics
  1. 2.1 Carbetocin (Duratocin) Industry Trends
  2. 2.2 Carbetocin (Duratocin) Industry Drivers
  3. 2.3 Carbetocin (Duratocin) Industry Opportunities and Challenges
  4. 2.4 Carbetocin (Duratocin) Industry Restraints
3 Carbetocin (Duratocin) Market by Manufacturers
  1. 3.1 Global Carbetocin (Duratocin) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Carbetocin (Duratocin) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Carbetocin (Duratocin) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Carbetocin (Duratocin) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Carbetocin (Duratocin) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Carbetocin (Duratocin) Manufacturers, Product Type & Application
  7. 3.7 Global Carbetocin (Duratocin) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Carbetocin (Duratocin) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Carbetocin (Duratocin) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Carbetocin (Duratocin) Tier 1, Tier 2, and Tier 3
4 Carbetocin (Duratocin) Market by Type
  1. 4.1 Carbetocin (Duratocin) Type Introduction
  2. 4.1.1 Carbetocin Tablets
  3. 4.1.2 Carbetocin Injection
  4. 4.2 Global Carbetocin (Duratocin) Sales by Type
  5. 4.2.1 Global Carbetocin (Duratocin) Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Carbetocin (Duratocin) Sales by Type (2021-2032)
  7. 4.2.3 Global Carbetocin (Duratocin) Sales Market Share by Type (2021-2032)
  8. 4.3 Global Carbetocin (Duratocin) Revenue by Type
  9. 4.3.1 Global Carbetocin (Duratocin) Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Carbetocin (Duratocin) Revenue by Type (2021-2032)
  11. 4.3.3 Global Carbetocin (Duratocin) Revenue Market Share by Type (2021-2032)
5 Carbetocin (Duratocin) Market by Application
  1. 5.1 Carbetocin (Duratocin) Application Introduction
  2. 5.1.1 Oxytocic
  3. 5.1.2 Antihemorrhagic
  4. 5.1.3 Uterotonic
  5. 5.2 Global Carbetocin (Duratocin) Sales by Application
  6. 5.2.1 Global Carbetocin (Duratocin) Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Carbetocin (Duratocin) Sales by Application (2021-2032)
  8. 5.2.3 Global Carbetocin (Duratocin) Sales Market Share by Application (2021-2032)
  9. 5.3 Global Carbetocin (Duratocin) Revenue by Application
  10. 5.3.1 Global Carbetocin (Duratocin) Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Carbetocin (Duratocin) Revenue by Application (2021-2032)
  12. 5.3.3 Global Carbetocin (Duratocin) Revenue Market Share by Application (2021-2032)
6 Global Carbetocin (Duratocin) Sales by Region
  1. 6.1 Global Carbetocin (Duratocin) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Carbetocin (Duratocin) Sales by Region (2021-2032)
  3. 6.2.1 Global Carbetocin (Duratocin) Sales by Region (2021-2026)
  4. 6.2.2 Global Carbetocin (Duratocin) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Carbetocin (Duratocin) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Carbetocin (Duratocin) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Carbetocin (Duratocin) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Carbetocin (Duratocin) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Carbetocin (Duratocin) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Carbetocin (Duratocin) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Carbetocin (Duratocin) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Carbetocin (Duratocin) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Carbetocin (Duratocin) Revenue by Region
  1. 7.1 Global Carbetocin (Duratocin) Revenue by Region
  2. 7.1.1 Global Carbetocin (Duratocin) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Carbetocin (Duratocin) Revenue by Region (2021-2026)
  4. 7.1.3 Global Carbetocin (Duratocin) Revenue by Region (2027-2032)
  5. 7.1.4 Global Carbetocin (Duratocin) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Carbetocin (Duratocin) Revenue (2021-2032)
  8. 7.2.2 North America Carbetocin (Duratocin) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Carbetocin (Duratocin) Revenue (2021-2032)
  11. 7.3.2 Europe Carbetocin (Duratocin) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Carbetocin (Duratocin) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Carbetocin (Duratocin) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Carbetocin (Duratocin) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Carbetocin (Duratocin) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Ferring Inc.
  2. 8.1.1 Ferring Inc. Company Information
  3. 8.1.2 Ferring Inc. Business Overview
  4. 8.1.3 Ferring Inc. Carbetocin (Duratocin) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Ferring Inc. Carbetocin (Duratocin) Product Portfolio
  6. 8.1.5 Ferring Inc. Recent Developments
  7. 8.2 Hangzhou Dayangchem Co. Ltd.
  8. 8.2.1 Hangzhou Dayangchem Co. Ltd. Company Information
  9. 8.2.2 Hangzhou Dayangchem Co. Ltd. Business Overview
  10. 8.2.3 Hangzhou Dayangchem Co. Ltd. Carbetocin (Duratocin) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Hangzhou Dayangchem Co. Ltd. Carbetocin (Duratocin) Product Portfolio
  12. 8.2.5 Hangzhou Dayangchem Co. Ltd. Recent Developments
  13. 8.3 Acinopeptide Co., Ltd.
  14. 8.3.1 Acinopeptide Co., Ltd. Company Information
  15. 8.3.2 Acinopeptide Co., Ltd. Business Overview
  16. 8.3.3 Acinopeptide Co., Ltd. Carbetocin (Duratocin) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Acinopeptide Co., Ltd. Carbetocin (Duratocin) Product Portfolio
  18. 8.3.5 Acinopeptide Co., Ltd. Recent Developments
  19. 8.4 Polypeptide Laboraries France
  20. 8.4.1 Polypeptide Laboraries France Company Information
  21. 8.4.2 Polypeptide Laboraries France Business Overview
  22. 8.4.3 Polypeptide Laboraries France Carbetocin (Duratocin) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Polypeptide Laboraries France Carbetocin (Duratocin) Product Portfolio
  24. 8.4.5 Polypeptide Laboraries France Recent Developments
  25. 8.5 Leap Labchem Co., Ltd
  26. 8.5.1 Leap Labchem Co., Ltd Company Information
  27. 8.5.2 Leap Labchem Co., Ltd Business Overview
  28. 8.5.3 Leap Labchem Co., Ltd Carbetocin (Duratocin) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Leap Labchem Co., Ltd Carbetocin (Duratocin) Product Portfolio
  30. 8.5.5 Leap Labchem Co., Ltd Recent Developments
  31. 8.6 Clearsynth Canada INC.
  32. 8.6.1 Clearsynth Canada INC. Company Information
  33. 8.6.2 Clearsynth Canada INC. Business Overview
  34. 8.6.3 Clearsynth Canada INC. Carbetocin (Duratocin) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Clearsynth Canada INC. Carbetocin (Duratocin) Product Portfolio
  36. 8.6.5 Clearsynth Canada INC. Recent Developments
  37. 8.7 Chemos GmbH & Co. KG
  38. 8.7.1 Chemos GmbH & Co. KG Company Information
  39. 8.7.2 Chemos GmbH & Co. KG Business Overview
  40. 8.7.3 Chemos GmbH & Co. KG Carbetocin (Duratocin) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Chemos GmbH & Co. KG Carbetocin (Duratocin) Product Portfolio
  42. 8.7.5 Chemos GmbH & Co. KG Recent Developments
  43. 8.8 Chemieliva Pharmaceutical Co., Ltd.
  44. 8.8.1 Chemieliva Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Chemieliva Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Chemieliva Pharmaceutical Co., Ltd. Carbetocin (Duratocin) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Chemieliva Pharmaceutical Co., Ltd. Carbetocin (Duratocin) Product Portfolio
  48. 8.8.5 Chemieliva Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 BOC Sciences
  50. 8.9.1 BOC Sciences Company Information
  51. 8.9.2 BOC Sciences Business Overview
  52. 8.9.3 BOC Sciences Carbetocin (Duratocin) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 BOC Sciences Carbetocin (Duratocin) Product Portfolio
  54. 8.9.5 BOC Sciences Recent Developments
  55. 8.10 Beacon Pharmaceuticals Limited
  56. 8.10.1 Beacon Pharmaceuticals Limited Company Information
  57. 8.10.2 Beacon Pharmaceuticals Limited Business Overview
  58. 8.10.3 Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Product Portfolio
  60. 8.10.5 Beacon Pharmaceuticals Limited Recent Developments
  61. 8.11 Bachem AG
  62. 8.11.1 Bachem AG Company Information
  63. 8.11.2 Bachem AG Business Overview
  64. 8.11.3 Bachem AG Carbetocin (Duratocin) Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Bachem AG Carbetocin (Duratocin) Product Portfolio
  66. 8.11.5 Bachem AG Recent Developments
  67. 8.12 Acinopeptide Co., Ltd.
  68. 8.12.1 Acinopeptide Co., Ltd. Company Information
  69. 8.12.2 Acinopeptide Co., Ltd. Business Overview
  70. 8.12.3 Acinopeptide Co., Ltd. Carbetocin (Duratocin) Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Acinopeptide Co., Ltd. Carbetocin (Duratocin) Product Portfolio
  72. 8.12.5 Acinopeptide Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Carbetocin (Duratocin) Value Chain Analysis
  2. 9.1.1 Carbetocin (Duratocin) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Carbetocin (Duratocin) Production Mode & Process
  6. 9.2 Carbetocin (Duratocin) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Carbetocin (Duratocin) Distributors
  9. 9.2.3 Carbetocin (Duratocin) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst